Search research articles
Contact Us
Filters
Showing results (1-10 of 111) with videos related to
Page
of 12
Sort By:
Digestive Diseases (Basel, Switzerland)
|
March 17, 2016
Anti-TNFs: Originators and Biosimilars
Gerassimos J Mantzaris
Digestive Diseases (Basel, Switzerland)
|
December 23, 2014
Previous cancer and/or lymphoma in patients with refractory IBD--con: anti-TNF or conventional immunosuppressive treatment
Gerassimos J Mantzaris
Best Practice & Research. Clinical Gastroenterology
|
June 11, 2014
When can we cure Crohn's?
Gerassimos J Mantzaris
Current Treatment Options in Gastroenterology
|
February 5, 2017
Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era
Gerassimos J Mantzaris
Alimentary Pharmacology & Therapeutics
|
December 8, 2022
Editorial: symptoms predicting active intestinal inflammation in patients with IBD
Gerassimos J Mantzaris
Journal of Crohn'S & Colitis
|
October 9, 2012
Reply to Dr. Yamamoto's letter
Konstantinos Papamichael, Gerassimos J Mantzaris
Alimentary Pharmacology & Therapeutics
|
July 26, 2022
Editorial: golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis
Gerassimos J Mantzaris, Konstantinos Papamichael
Scandinavian Journal of Gastroenterology
|
October 2, 2015
Author's reply to Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients: disease activity as an influencing factor
Gerassimos J Mantzaris, Konstantinos Papamichael
Alimentary Pharmacology & Therapeutics
|
February 18, 2021
Editorial: an expert consensus to standardise the assessment of histologic disease activity in Crohn's disease clinical trials-a missing link
Gerassimos J Mantzaris, Giorgos Bamias
Alimentary Pharmacology & Therapeutics
|
January 29, 2022
Letter: towards gender-stratified colorectal cancer screening and surveillance?
Vasilios Papastergiou, Nikos Viazis, Gerassimos J Mantzaris
Page
of 12
Search research articles
Search
Showing results (1-10 of 111) with videos related to
Sort By:
Page
of 12
Digestive Diseases (Basel, Switzerland)
|
March 17, 2016
Anti-TNFs: Originators and Biosimilars
Gerassimos J Mantzaris
Digestive Diseases (Basel, Switzerland)
|
December 23, 2014
Previous cancer and/or lymphoma in patients with refractory IBD--con: anti-TNF or conventional immunosuppressive treatment
Gerassimos J Mantzaris
Best Practice & Research. Clinical Gastroenterology
|
June 11, 2014
When can we cure Crohn's?
Gerassimos J Mantzaris
Current Treatment Options in Gastroenterology
|
February 5, 2017
Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era
Gerassimos J Mantzaris
Alimentary Pharmacology & Therapeutics
|
December 8, 2022
Editorial: symptoms predicting active intestinal inflammation in patients with IBD
Gerassimos J Mantzaris
Journal of Crohn'S & Colitis
|
October 9, 2012
Reply to Dr. Yamamoto's letter
Konstantinos Papamichael, Gerassimos J Mantzaris
Alimentary Pharmacology & Therapeutics
|
July 26, 2022
Editorial: golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis
Gerassimos J Mantzaris, Konstantinos Papamichael
Scandinavian Journal of Gastroenterology
|
October 2, 2015
Author's reply to Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients: disease activity as an influencing factor
Gerassimos J Mantzaris, Konstantinos Papamichael
Alimentary Pharmacology & Therapeutics
|
February 18, 2021
Editorial: an expert consensus to standardise the assessment of histologic disease activity in Crohn's disease clinical trials-a missing link
Gerassimos J Mantzaris, Giorgos Bamias
Alimentary Pharmacology & Therapeutics
|
January 29, 2022
Letter: towards gender-stratified colorectal cancer screening and surveillance?
Vasilios Papastergiou, Nikos Viazis, Gerassimos J Mantzaris
Page
of 12